Back
Perspective Therapeutics Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
84
CATX
Perspective Therapeutics
Last Price:
1.81
Seasonality Move:
3.58%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.32 | Buy |
| 200-day SMA: | 0.65 | Buy |
| 8-day EMA: | 1.69 | Buy |
| 20-day EMA: | 1.58 | Buy |
| 50-day EMA: | 1.34 | Buy |
| 200-day EMA: | 0.82 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 71.56 | Buy |
| Chaikin Money Flow: | 940587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.66) | Buy |
| Bollinger Bands (100): | (0.51 - 1.39) | Buy |
Perspective Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 1.81 while CATX 8-day simple moving average is 1.68, which is a Buy signal.
- The stock price of CATX is 1.81 while Perspective Therapeutics 20-day SMA is 1.58, which makes it a Buy.
- Perspective Therapeutics 50-day simple moving average is 1.32 while CATX share price is 1.81, making it a Buy technically.
- CATX stock price is 1.81 and Perspective Therapeutics 200-day simple moving average is 0.65, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Buy
84
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Buy
The current Perspective Therapeutics [CATX] share price is $1.81. The Score for CATX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
1.06B
Price in USD:
1.81
Share Volume:
4.7M
Perspective Therapeutics 52-Week Range
52-Week High:
1.87
52-Week Low:
0.21
Buy
84
Perspective Therapeutics (CATX)
is a Buy
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 1.81 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is not overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 1.81 while CATX 8-day exponential moving average is 1.69, which is a Buy signal.
- The stock price of CATX is 1.81 while Perspective Therapeutics 20-day EMA is 1.58, which makes it a Buy.
- Perspective Therapeutics 50-day exponential moving average is 1.34 while CATX share price is 1.81, making it a Buy technically.
- CATX stock price is 1.81 and Perspective Therapeutics 200-day simple moving average is 0.82, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Perspective Therapeutics is a Buy
- Perspective Therapeutics Relative Strength Index (RSI) is 71.56, which suggest Perspective Therapeutics is overbought
- The Bollinger Bands (25) for Perspective Therapeutics is (1.42 - 1.66), which suggest Perspective Therapeutics is a Buy
- The Bollinger Bands (100) for Perspective Therapeutics is (0.51 - 1.39), which suggest Perspective Therapeutics is a Buy
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.